论文 ID ATH-589YFS · 二区论文 · 金融经济学

Cost–effectiveness thresholds: pros and cons CC-BY

这是一篇从 Bulletin of the World Health Organization 导入的开放获取论文,用于长期保存;它并非本站投稿,因此不设版本历史与时间戳历史。

  • 原出版日期:2016年11月30日 UTC
  • 权利状态:CC-BY(未记录届满日期)
  • 加入本站:2026年10月3日 UTC
  • Melanie Bertram World Health Organization
  • Jeremy Addison Lauer World Health Organization
  • Kees de Joncheere World Health Organization
  • Tessa Tan-Torres Edejer World Health Organization
  • Raymond C. W. Hutubessy World Health Organization
  • Marie-Paule Kiény World Health Organization
  • Suzanne Rose Hill World Health Organization

提交者 AthenXiv UW2JTS24Y · 发表时间 2026年10月3日 UTC · 713 浏览量 · 24 下载量 · 495 KB · English

由以下人员代作者上传 AthenXiv (UW2JTS24Y)

在线阅读 下载 PDF (495 KB)

摘要

Cost-effectiveness analysis is used to compare the costs and outcomes of alternative policy options. Each resulting cost-effectiveness ratio represents the magnitude of additional health gained per additional unit of resources spent. Cost-effectiveness thresholds allow cost-effectiveness ratios that represent good or very good value for money to be identified. In 2001, the World Health Organization's Commission on Macroeconomics in Health suggested cost-effectiveness thresholds based on multiples of a country's per-capita gross domestic product (GDP). In some contexts, in choosing which health interventions to fund and which not to fund, these thresholds have been used as decision rules. However, experience with the use of such GDP-based thresholds in decision-making processes at country level shows them to lack country specificity and this - in addition to uncertainty in the modelled cost-effectiveness ratios - can lead to the wrong decision on how to spend health-care resources. Cost-effectiveness information should be used alongside other considerations - e.g. budget impact and feasibility considerations - in a transparent decision-making process, rather than in isolation based on a single threshold value. Although cost-effectiveness ratios are undoubtedly informative in assessing value for money, countries should be encouraged to develop a context-specific process for decision-making that is supported by legislation, has stakeholder buy-in, for example the involvement of civil society organizations and patient groups, and is transparent, consistent and fair.

关键词: Health Systems, Economic Evaluations, Quality of Life, Economics and Econometrics, Economics, Econometrics and Finance, Social Sciences

DOI: 10.2471/blt.15.164418

许可协议: CC-BY

在线阅读

引用本文

BibTeX RIS 纯文本 JSON

Melanie Bertram, Jeremy Addison Lauer, Kees de Joncheere, Tessa Tan-Torres Edejer, Raymond C. W. Hutubessy, Marie-Paule Kiény, Suzanne Rose Hill (2026). Cost–effectiveness thresholds: pros and cons. AthenXiv. https://athenxiv.com/paper/ATH-589YFS